A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Clinical trial NCT06544499 · RECRUITING
Trial details
- NCT number
- NCT06544499
- Sponsor
- argenx
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-18
- Primary completion
- 2028-06-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.